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Autoreactive CD8+ and CD4+ T cells have been assigned independent key roles in the 
destruction of insulin-producing beta cells resulting in type 1 diabetes. Although CD4 
help for the generation of efficient CD8+ T cell responses in lymphoid tissue has been 
extensively described, whether these two cell populations cooperate in islet destruction 
in situ remains unclear. By using intravital 2-photon microscopy in a mouse model of 
diabetes, we visualized both effector T cell populations in the pancreas during disease 
onset. CD4+ T helper cells displayed a much higher arrest in the exocrine tissue than 
islet-specific CD8+ T cells. This increased arrest was major histocompatibility complex 
(MHC) class II-dependent and locally correlated with antigen-presenting cell recruitment. 
CD8+ T  cells deprived of continued CD4 help specifically in the pancreas, through 
blocking MHC class II recognition, failed to maintain optimal effector functions, which 
contributed to hamper diabetes progression. Thus, we provide novel insight in the cellu-
lar mechanisms regulating effector T cell functionality in peripheral tissues with important 
implications for immunotherapies.
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inTrODUcTiOn
Type 1 diabetes (T1D) is an autoimmune disease characterized by progressive infiltration of pancre-
atic islets of Langerhans by immune cells and subsequent destruction of insulin-producing beta cells. 
Disease development reflects a failure of immune tolerance mechanisms that control self-reactive 
T cells (1). Although the exact composition of immune cells in diabetic lesions varies with time, 
T cells usually dominate in T1D patients (2). Both CD4+ helper and CD8+ cytotoxic T cells (CTLs) 
are present, and there is a large body of evidence indicating that both are key effectors in T1D devel-
opment (2, 3). Indeed, most identified susceptibility loci contain candidate genes that are involved 
in T cell activation and regulation, and specific major histocompatibility complex (MHC) class II 
and, to a lesser extent, MHC class I haplotypes confer predisposition to diabetes development (1, 3).
Disease onset involves two sequential steps in anatomically distinct tissues. First, autoreactive 
T cells, which have evaded tolerance checkpoints, are activated in the lymph nodes draining the 
pancreas (pLN) by antigen-presenting cells (APCs) that display beta cell antigens (4, 5). At this stage, 
CD4+ T cells are required for efficient activation of CD8+ T cells (6–8). Second, activated effector 
T cells infiltrate the pancreas (9). While infiltrating effector CD4+ T cells are thought to contribute to 
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beta cell death through macrophage activation (10), CD8+ T cells 
(11) are able to directly kill beta cells in an antigen-dependent 
manner (9, 12). In addition, both effector T  cells engage in 
antigen-dependent contacts with APCs, which are required to 
maintain effector function over time in the pancreas, at least for 
CD8+ T cells (13, 14). These interactions appear to be crucial for 
the maintenance of cytotoxic properties in the periphery (15, 16).
Dynamics of T cell activation in secondary lymphoid organs, 
including pLN (17), have been extensively studied for over a 
decade in mouse models using two-photon microscopy. These 
studies have provided a framework for understanding the role of 
different patterns of dynamic interactions with APCs, leading to 
either T cell priming or tolerance induction (17, 18). Moreover, 
they highlighted the importance of cooperation between T cells in 
the generation of immune responses. In particular, recent studies 
have revealed a complex choreography of sequential interactions 
among APCs, CD4+, and CD8+ T cells in lymphoid organs dur-
ing priming and the existence of a specialized dendritic cell (DC) 
subtype that may serve as a platform for CD4+ and CD8+ T cell 
cooperation (19, 20). Diabetogenic CD8+ or CD4+ T cell dynam-
ics have been studied in pancreatic islets (9, 14, 21). However, 
visualizing T cell responses in deep organs such as the pancreas 
in vivo remains challenging and functional cooperation between 
CD8+ or CD4+ T cell populations in the pancreas during T1D 
remains unexplored.
In this study, we therefore set out to understand how effector 
CD8+ and CD4+ T cells cooperate in islet destruction during the 
onset of T1D. To allow this, intravital imaging approaches were 
applied directly to the pancreas in a mouse model of autoimmune 




Mice were bred in SPF facility and housed in conventional 
facility during experimentation. To induce diabetes, we used 
the InsHA transgenic mouse model. Balb/c InsHA mice express 
the influenza virus hemagglutinin (HA) under the control of 
rat insulin promoter, driving its expression in pancreatic beta 
cells (22). Balb/c clone 4 TCR and HNT TCR transgenic mice 
express HA-specific MHC class I and class II restricted TCRs, 
respectively (23, 24). Naive clone 4 CD8+ and HNT CD4+ T cells 
adoptively co-transferred into sublethally irradiated InsHA mice 
undergo lymphopenia-induced proliferation and differentiate 
into memory-like cells (6). Under these conditions, HNT CD4+ 
T cells promote the further differentiation of clone 4 CD8+ T cells 
into effectors in the draining lymph nodes of the pancreas, their 
migration to the pancreas, and onset of autoimmune diabetes (6). 
InsHA (22), clone 4 TCR (23), and HNT TCR (24) were kindly 
provided by L. A. Sherman (The Scripps Research Institute, 
San Diego, CA, USA). For imaging purposes, fluorescent labels 
were introduced in beta cells by crossing InsHA mice with RIP-
mCherry mice (25), and clone 4 TCR and HNT TCR transgenic 
mice were crossed with actin-GFP and actin-CFP transgenic 
mice, respectively. RIP-mCherry mice (25) were provided by 
P. Le Tissier and I. C. Robinson (National Institute of Medical 
Research, London, UK), and β-actin-GFP and β-actin-CFP mice 
were from the Jackson Laboratory. InsHA, clone 4 TCR, and 
HNT TCR were backcrossed with BALB/c Thy1.1+/+ mice for >15 
generations, while RIP-mCherry, β-actin-GFP, and β-actin-CFP 
mice were backcrossed with C57BL/6 mice for >15 generations. 
F1 clone 4 TCR Thy1.1 × actin-GFP (clone 4-GFP), F1 HNT TCR 
Thy1.1 × actin-CFP (HNT-CFP), and F1 InsHA × RIP-mCherry 
mice on BALB/c × C57BL/6 background 10–16 weeks of age were 
used. More than 98% of the CD8+ T cells from clone 4-GFP mice 
were Vβ8.2+, and 93% of the CD4+ T cells from HNT-CFP mice 
were Vβ8.3+.
T cell isolation, adoptive Transfer, and 
Diabetes Monitoring
Naive CD8+ T cells from clone 4 TCR Thy1.1 × β-actin-GFP and 
CD4+ T  cells from HNT TCR Thy1.1 ×  β-actin-CFP F1 mice 
were prepared from LN and spleen using T  cells isolation kits 
(Dynabeads, Thermo Fisher Scientific). Equal numbers (2–3 × 106 
cells/recipient) of CD8+ and CD4+ T cells were injected i.v. into 
InsHA × RIP-mCherry mice sublethally irradiated (4.5 Gy) 24 h 
before in a therapeutic irradiator (Varian). Some mice received 
either CD8+ or CD4+ T cells (2–3 × 106 cells/recipient) separately. 
Recipient mice blood glucose levels were monitored using a 
glucometer (AccuCheck). All experiments used normoglycemic 
mice, except for diabetes-onset kinetics and survival analyses, in 
which diabetic mice (>300 mg/dl of blood glucose for 2 consecu-
tive days) were monitored daily and euthanized at first signs of 
distress.
surgery and intravital imaging
Mice pancreas was exteriorized by surgery as described (25). 
Briefly, animals were anesthetized by injection of ketamine/xyla-
zine (0.1/0.02 mg/g). Respiration was controlled by tracheotomy to 
limit tissue movement. The pancreas was gently maneuvered onto 
a metallic stage covered with a soft polymer (Bluesil) and pinned 
using stainless steel minutien insect pins (tip = 0.0125 mm). The 
tissue was continuously superfused with a NaCl 0.9% heated to 
37°C. Fluorescent lymphocytes and beta cells were visualized 
using a multiphoton microscope (Zeiss 7MP) adapted with 
a long-working distance objective M Plan Apo NIR ×  20, 0.4 
NA (Mitutoyo). Excitation was achieved using a Ti:Sapphire 
Chameleon Laser (Coherent) tuned to either 820 nm (mCherry 
and mCherry-GFP-CFP excitation), 850  nm (rhodamine-GFP-
CFP), 880 nm (GFP-CFP), or 910 nm (rhodamine-GFP). Emitted 
fluorescence was captured using GaAsP photomultiplier tubes at 
460–500 nm for CFP, 500–550 nm for GFP, and 610–700 nm for 
mCherry and rhodamine. Surface islets (<100 µm in depth) were 
identified using mCherry or by light contrast. Tissue viability 
was verified by rhodamine-dextran i.v. injection and detection of 
blood flow as described (25).
image Data analysis
Stacks 150–250 µm thick (Z steps of 3 µm) were acquired every 
30 s to 1 min for 10–20 min. Movies were stabilized using Huygens 
Essential (SVI). Only areas with similar infiltration levels were 
compared. Fields presenting <20 and >500  T  cells/0.05  mm3 
(imaging stack volume) were excluded from analysis. Mild and 
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severe infiltration areas were defined as presenting less or more 
than 150  T  cells/0.05  mm3, respectively. Measurements were 
performed in at least three independent experiments. Average 
velocities and instantaneous speeds were obtained using Imaris 
(Bitplane). Arrest coefficients (percentage of time points at 
instantaneous velocities below 3 µm/min) were calculated using 
a MATLAB routine (26). T cell coordinates obtained using Imaris 
were imported in MATLAB to generate graphs of XY projections 
of T cell tracks. Tracks lasting <4 min were excluded. No exclu-
sion was made based on velocity. Cellular contacts were manually 
quantified and verified by rotations in Z using Imaris.
Flow cytometry
For T  cell phenotyping, pancreas, pLN, and peripheral LN 
were processed and stained as described (6). The mAbs used 
were as follows: anti-CD4-BV711, anti-CD4-FITC, anti-CD8a-
BV786, anti-CD8a-FITC, anti-Thy1.1-PerCP, anti-CD62L-APC, 
anti-INFγ-PE, anti-CD45RB-PE, and anti-CD107a-PE (BD 
PharMingen); anti-CD25-APC-eFluor780, anti-Granzyme B-PE, 
anti-KLRG1-PE-Cy7, and anti-FoxP3-PerCP-Cy5.5 (eBiosci-
ence). Cells were analyzed on a FACSCanto II or a LSR Fortessa 
apparatus using Diva software (BDB). Isotype-matched antibod-
ies were used as controls. Intracellular Granzyme B and Foxp3 
staining was performed using the Fixation and Permeabilization 
Kit (eBioscience). Intracellular IFNγ and IL-2 staining was per-
formed after 5 h restimulation with HA peptide using the Cytofix/
Cytoperm Kit (BD PharMingen) (6).
In Vivo antibody Treatment
Anti-MHC class II (I-A/I-E) (clone M5/114, BioXcell) and isotype 
control antibody [rat IgG2b/anti-KLH (BioXcell)] were either 
injected through a jugular catheter on day 8 after T cell transfer 
>1 h before imaging (200 μg/animal) or i.p. on days 8 (200 µg) 
and 9 (100  µg) after T  cell transfer and mice were euthanized 
at day 10 for FACS analysis. For survival analysis, mice received 
200 µg i.p. on day 8 and 100 µg every 3 days until sacrifice.
confocal imaging
Pancreata were fixed in 4% paraformaldehyde and sliced on 
a vibratome (Leica) (100  µm), or snap-frozen and cryostat-
sectioned slices (20 µm) were fixed with 1.5% paraformaldehyde. 
Immediate fixation was necessary to preserve CFP and GFP 
fluorescence. Antibody labeling was done as described previously 
(27). The antibodies used were as follows: hamster anti-CD11c 
(N418, eBioscience), rat anti-F4/80 (MCA4976, BioRad), rabbit 
anti-insulin (Cell Signaling), and rat anti-endomucin (Santa Cruz 
Biotechnology). Nuclei were labeled using dapi (Sigma). Images 
were acquired using a Zeiss LSM 780 confocal microscope and 
analyzed using Imaris (Bitplane), Volocity (Perkin Elmer), and 
ImageJ (NIH). One to four slices were randomly selected from 
at least three animals per group. For quantification of infiltrated 
islets, four slices were randomly selected from pancreas from at 
least three animals per group, and all islets present were analyzed 
(>60 islets/mouse). For quantification of T cells–APCs contacts, 
four slices were randomly selected from at least three animals per 
group, and all cells present in a minimum of 10 different confocal 
images (700 μm × 700 μm × 20 μm) were analyzed.
statistical analysis
Values are represented as means ±  SEM. Statistical tests were 
performed using GraphPad Prism. Normality was tested using 
D’Agostino-Pearson test, and comparisons were made using 
either unpaired Student’s t-test or two-tailed Mann–Whitney 
U-test, as appropriate. Multiple comparisons were made using 
one-way ANOVA followed by Bonferroni’s post hoc test. P values 
were considered significant at *P < 0.05, **P < 0.01, ***P < 0.001, 
and ****P < 0.0001.
resUlTs
simultaneous intravital imaging of islet 
antigen-specific cD8+ and cD4+ T cell 
Behavior
To study the interplay of effector CD8+ and CD4+ T cells during 
pancreas infiltration leading to beta cell destruction, we utilized 
InsHA transgenic mice that express the influenza HA antigen in 
beta cells. On adoptive transfer into InsHA mice, both HA-specific 
TCR transgenic clone 4 CD8+ and HNT CD4+ T cells (MHC class 
I or II restricted, respectively) are required to induce diabetes 
under inflammatory conditions (8). In this model, CD4+ T helper 
cells are essential for CD8+ T cell differentiation into CTLs in the 
pLN (6). Here, fluorescent labels were introduced into beta cells 
(mCherry), clone 4 CD8+ (GFP), and HNT CD4+ (CFP) T cells. 
As expected (6), naive clone 4-GFP CD8+ T cells co-transferred 
with HNT-CFP CD4+ T cells into sublethally irradiated InsHA-
mCherry hosts expanded after day 6 posttransfer, differentiated 
into CTL in the pLN and migrated to the pancreas, together 
with HNT-CFP CD4+ T cells (Figures S1A–E in Supplementary 
Material). Of note, from 77 to 93% of GFP and CFP cells found 
in InsHA-mCherry hosts corresponded to Thy1.1+ CD8+ and 
Thy1.1+ CD4+ T cells, respectively (Figure S1F in Supplementary 
Material). This resulted in autoimmune diabetes in all mice tested 
(Figure  1A). In the absence of HNT-CFP CD4+ T  cells, clone 
4-GFP CD8+ T cells did not differentiate into effectors in the pLN, 
as evidenced by the lack of expression of CD25, Granzyme B, 
and KLRG1 as well as the high expression of CD62L, and were 
unable to migrate to the pancreas (Figure  1A; Figures S2A–C 
in Supplementary Material). However, clone 4-GFP CD8+ T cells 
from all LN were able to secrete low amounts of IFNγ (Figure S2B 
in Supplementary Material), a general phenomenon observed 
when naive T cells are transferred into irradiated mice (28). In 
contrast, both phenotype and capacity of HNT-CFP CD4+ T cells 
to migrate to the pancreas were independent of clone 4-GFP 
CD8+ T  cells (Figures S1A,D,E and S2D–F in Supplementary 
Material). However, HNT-CFP CD4+ T cells alone did not induce 
diabetes (Figure 1A), predominantly remaining in a peri-insu-
litic disposition before clearance (Figure S3 in Supplementary 
Material). The HNT-CFP CD4+ T  cell population contained a 
small subset of FoxP3+ CD25+ cells whose proportion, 4–5%, 
also remained constant regardless of the presence or absence of 
donor CD8+ T cells or the anatomical location (Figures S1C and 
S2C in Supplementary Material). Taken together, these results 
demonstrate that our autoimmune diabetes model in a mixed 
FigUre 1 | Infiltration and in vivo motility of islet antigen-specific CD8+ and CD4+ T cells in the pancreas. (a) Blood glucose levels of irradiated InsHA-mCherry mice 
as function of days posttransfer of either HNT-GFP CD4+, clone 4-GFP CD8+, or clone 4-GFP CD8+ and  HNT-CFP CD4+ T cells (n = 3–48 mice/condition). (B) 
Percentage of infiltrated islets in irradiated InsHA-mCherry mice transferred with clone 4-GFP CD8+ and HNT-CFP CD4+ T cells as function of days posttransfer 
(n = 3–7 mice/day, >150 islets/mouse). (c) Representative confocal images of pancreas at day 8 and 12 posttransfer of mice described in (B) (scale: 200 µm, 
25 µm Z-projection). (D) Still image from a representative movie in the pancreas of a mouse described in (B) at day 8 posttransfer (scale: 50 µm, Z-projection of 
200 µm) (Video S1 in Supplementary Material). Green, CD8+; blue, CD4+; red, beta cells. Islet is circled. (e) T cells tracks from field in (D), color-coded as function of 
time. Total duration: 18.3 min. (F,g) Average T cell velocities (F) and arrest coefficients (g) (% time points spent at <3 µm/min for each track) in exocrine (outside of 
circle around mCherry signal) and endocrine (inside of circle) tissues at day 8 posttransfer (n = 3–5 mice/condition; 1–2 movies/mouse with an islet in the field, 
one-way ANOVA). Dots correspond to individual T cells. (h,i) Still images from representative movies of areas of a single pancreas at day 8 posttransfer presenting 
either mild (h) (<150 CFP and GFP cells/0.05 mm3) or severe (i) (>150) infiltration (scale: 100 µm, 160 µm Z-projection) (Video S3 in Supplementary Material). (J) 
Ratio of CFP to GFP cells in exocrine tissue (n = 3–5 mice/condition; 1–2 movies/mouse, one-way ANOVA). Dots correspond to individual movies. (K) Average 
T cell velocities at day 8 posttransfer in either mildly or severely infiltrated areas close to islets (<600 µm) or away (>600 µm) (n = 3–5 mice/condition; 1–2 movies/
mouse, one-way ANOVA) (see also Video S5 in Supplementary Material). Values are represented as mean ± SEM.
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background resembles closely to that previously described in a 
Balb/c background (6).
Analysis of islet infiltration in InsHA-mCherry mice co-
transferred with clone 4-GFP and HNT-CFP T  cells demon-
strated progressive insulitis (Figures  1B,C), which coincided 
with rapid and synchronized increase in blood glucose levels 
from day 8 posttransfer (Figure  1A). Different lobes of the 
pancreas presented varying infiltration levels at day 8, and 
infiltrated islets were irregularly distributed. This reflects the 
spatiotemporal heterogeneity of the autoimmune attack, as 
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previously reported in other mouse models (14, 29) and human 
patients (2, 30). We therefore analyzed T cell dynamics at that 
particular time point to cover a broad range of islet infiltration 
levels. By using a recently described two-photon microscopy 
approach (25), we were able to visualize beta cells, clone 4-GFP, 
and HNT-CFP T  cells in prediabetic InsHA-mCherry mice 
(Figure  1D; Video S1 in Supplementary Material) and track 
T  cell motility (Figure  1E). Both T  cell types accumulated in 
islets and surrounding exocrine tissue (Figure 1D). Clone 4-GFP 
CD8+ T cells displayed significantly higher average velocity and 
lower arrest coefficient (percentage of time points at velocity 
<3 µm/min) than HNT-CFP CD4+ T cells (7 vs. 5 µm/min, and 
47 vs. 59%, respectively) in exocrine tissue (Figures 1F,G). By 
contrast, both cells types behaved similarly within islets and 
displayed lower average velocity (~3.5  µm/min) and higher 
arrest coefficients (>80%) (Figures  1F,G). In correlation with 
their higher arrest, most clone 4-GFP CD8+ T cells within islets 
engaged in contacts with beta cells (Video S2 in Supplementary 
Material). Although these interactions were presumably leading 
to beta cell destruction, the described (9) rare fluorescent tag 
extinction in beta cells was not observed here over the imaging 
time course used.
Since variable numbers of T cells could be observed in imag-
ing fields at day 8, we evaluated separately T  cell behavior in 
mildly infiltrated (<150 cells/0.05 mm3) and severely infiltrated 
(>150 cells/0.05 mm3) areas of the exocrine tissue (outside islets) 
(Figures 1H,I; Video S3 in Supplementary Material). Mild infil-
tration was mainly observed in close proximity to islets (i.e., the 
exocrine tissue directly adjacent to an islet in the imaging field: 
<200 µm in Z, or <600 µm in X/Y). Therefore, heavily infiltrated 
areas with similar location parameters were chosen for compari-
son. We found that the shift from mild to severe infiltration in 
the exocrine tissue around islets was marked by a change in the 
CFP to GFP ratio from 1:1 to 1:2.5 (Figure 1J), possibly reflecting 
a differential influx of CD8+ T cells as infiltration progresses (2, 
29) and/or their proliferation in the pancreas (16), as could be 
observed here in vivo (Video S4 in Supplementary Material, total 
of three events observed over 6.25 h total elapsed movie time). In 
addition, we found that clone 4-GFP T cell motility in the exo-
crine tissue increased as a function of infiltration (Figure 1K). By 
contrast, HNT-CFP T cell motility was equivalent in mildly and 
heavily infiltrated areas (Figure 1K). Finally, we assessed whether 
the distance to the source of cognate antigen affected T cell motil-
ity. For this purpose, we imaged infiltrated fields in which no islet 
was visible. In this case, both clone 4-GFP CD8+ and HNT-CFP 
CD4+ T cells migrated with similar average velocities (distance 
>600 µm from an islet) (Figure 1K; Video S5 in Supplementary 
Material). However, HNT-CFP CD4+ T cells displayed increased 
motility compared to those in close vicinity to islets. To test 
whether migratory behavior of HA-specific T cells was antigen 
driven, we co-transferred either non-antigen-specific CD4+ or 
CD8+ T cells, in equal numbers, along with clone 4 CD8+ and 
HNT CD4+ T cells. However, non-HA-specific T cells, despite of 
being activated, failed to be recruited to the pancreas by day 8 
posttransfer in numbers sufficient for analysis (data not shown). 
Thus, the pancreas environment seems less permissive than other 
inflamed peripheral tissues like the brain to bystander effector 
T cell recruitment (26). Taken together, these results show that 
HA-specific CD8+ and CD4+ T cells display different kinetics of 
infiltration and migration in the exocrine tissue, suggesting that 
divergent mechanisms may be involved in the regulation of their 
motilities/arrest.
islet antigen-specific cD4+ T cell arrest 
correlates with local recruitment of 
Myeloid cells
An intriguing feature of HA-specific T  cell motility was that 
HNT-CFP T  cells spent significantly more time arrested than 
clone 4-GFP T cells in the exocrine tissue in islet vicinity. Since 
CD4+ T cell arrest is mostly driven by MHC class II-dependent 
interactions with APCs (18, 31), we analyzed leukocyte recruit-
ment accompanying pancreas infiltration. As expected (32), 
while a small population of resident macrophages and DCs 
could be detected in control irradiated non-transferred mice 
(Figure  2A), clone 4-GFP and HNT-CFP T  cell transfer pro-
moted the recruitment of F4/80+ and CD11c+ cells (Figure 2A). 
Notably, HNT-CFP CD4+ T cells transferred alone were able to 
induce such recruitment (Figure 2A). Recruited MHC class IIhi 
APCs mainly corresponded to DCs and macrophages (Figure 
S4 in Supplementary Material). While the majority of recruited 
DCs (62%) were from the CD11c+ CD103+ lineage, CD11c+ 
CD11b+ DCs were also present, as well as F4/80+ CD11bhi Ly6chi 
macrophages. APC recruitment coincided with T cell infiltration 
(Figure 2B). Overall, a large proportion of HNT-CFP and clone 
4-GFP T  cells were in close apposition to F4/80+ and CD11c+ 
APCs (>60 and >40%, respectively) (Figures 2C,D). This sug-
gests that different proportions of CD4+ and CD8+ T cells may 
interact with APCs at a given time point and could explain 
differences in T cell arrest in the exocrine tissue. Finally, about 
27% of HNT-CFP CD4+ and 9% of clone 4-GFP CD8+ T cells, 
respectively, were involved in three-cell type CD4+/CD8+/APCs 
contacts (Figures  2E,F). These findings suggest that three-cell 
type contacts may occur in vivo.
effector cD4+ T cell help support 
Diabetogenic cTl effector Function in the 
Pancreas
Recruited APCs may be able to present HA-derived peptides 
in the pancreas and mediate antigen-specific interactions with 
effector T cells (13, 14, 32). To investigate whether CD4+ T cell/
APC interactions modulate effector CD8+ T cell function in the 
pancreas, we treated InsHA-mCherry mice with either anti-MHC 
class II or control mAb prior to imaging. Motility of HNT-CFP 
CD4+ T  cells was greatly affected, and arrest coefficients in 
exocrine and endocrine tissues were significantly decreased 
(Figures  3A–D; Video S6 in Supplementary Material). These 
results indicate that MHC class II blockade efficiently prevented 
HNT-CFP CD4+ T cell lasting arrest on APCs.
Second, we evaluated the impact of preventing effector 
CD4+ T  cell/APC contacts on CTL function in the pancreas. 
Mice co-transferred with clone 4-GFP and HNT-CFP T cells 
were treated with either anti-MHC class II or isotype control, 
mAbs at a time when effector T cells had already been generated 
FigUre 2 | Islet antigen-specific CD4+ T cell arrest correlates with localized recruitment of myeloid cells at infiltration sites. (a) Representative confocal images of 
pancreas from irradiated non-transferred, irradiated co-transferred with clone 4-GFP CD8+ and  HNT-CFP CD4+, and irradiated transferred with HNT-CFP CD4+ 
InsHA-mCherry mice at day 8 posttransfer stained with the indicated mAbs (scale: 200 µm, Z-projection of 10 µm). (B) Representative confocal images of the 
pancreas from an irradiated InsHA-mCherry mouse at day 8 posttransfer of HNT-CFP CD4+ and clone 4-GFP CD8+ T cells (scale: 200 µm, Z-projection of 6 µm). 
Islets identified by dense DAPI staining are circled. (c) Representative confocal images of pancreas from mice described in (B) at day 8 posttransfer (scale 20 µm, 
single Z-plane) depicting HNT-CFP CD4+ (blue) and clone 4-GFP CD8+ (green) cells in contact with an F4/80+ (purple, top) or CD11c+ (white, bottom) cell. Cells in 
contact are circled. (D) Percentage of HNT-CFP CD4+ and clone 4-GFP CD8+ T cells in contact with F4/80+ and CD11c+ cells in the exocrine tissue (n = 3 mice, 
P < 0.0001, Mann–Whitney U-test). (e) Representative confocal images of pancreas from mice described in (B) at day 8 posttransfer (scale 20 µm, single Z-plane) 
depicting a three-cell contact (HNT/APC/clone 4) with a F4/80+ (purple, top) or CD11c+ (white, bottom) cell. Cells in contact are circled. (F) Percentage of HNT-CFP 
CD4+ and clone 4-GFP CD8+ T cells forming three-cell contacts with CD11c+ APCs in exocrine tissue (n = 3 mice, P < 0.0001, Mann–Whitney U-test). Values are 
represented as mean ± SEM.
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in the pLN and started infiltrating the pancreas (days 8–9 after 
transfer). At day 10, we found equivalent numbers of HNT-CFP 
CD4+ and clone 4-GFP CD8+ T cells in peripheral LN and pLN 
of both control and treated mice (Figure 4A), indicating that 
blocking antibody treatment at that time point did not prevent 
antigen-driven activation of HA-specific T cells in the pLN. In 
fact, comparable effector clone 4-GFP CD8+ T cells were gener-
ated in the pLN of treated and control mice (Figure 4B). Not 
surprisingly, we found significantly less HNT-CFP CD4+ and 
clone 4-GFP CD8+ T cell infiltration in the pancreas of treated 
mice (Figure 4C). CD4+ T cell extravasation has been shown 
to be antigen dependent in the pancreas (32), and CD8+ T cell 
recruitment is favored by CD4+ T cells (16). Thus, influx of effec-
tor T cells from day 8 may be impaired, and cells found at day 
10 may correspond to those that had already infiltrated the pan-
creas at day 8. Strikingly, important differences were observed 
in expression of markers linked to effector functions in clone 
4-GFP CD8+ T  cells (Granzyme B and CD25) (Figure  4D), 
as well as in their potential to secrete IFNγ (Figure S5A in 
Supplementary Material). Although in control mice, 62% of 
FigUre 3 | Major histocompatibility complex (MHC) class II-dependent CD4+ T cell arrest in the pancreas. (a) Irradiated InsHA-mCherry mice transferred with clone 
4-GFP CD8+ and HNT-CFP CD4+ T cells were subjected to intravital microscopy on day 8. XY projections of T cell tracks over 17.5 min are depicted. Recording 
started >1 h following isotype-matched control or anti-MHCII antibody i.v. injection (scale: 100 µm) (Video S6 in Supplementary Material). Numbers indicate track 
numbers in movies. (B) Average T cell velocities in the exocrine tissue at day 8 posttransfer (n = 3 mice/condition; 1–3 movies/mouse, one-way ANOVA). (c,D) 
Arrest coefficients in exocrine (c) or endocrine (D) tissues at day 8 (n = 3 mice/condition; 1–3 movies/mouse in areas with comparable levels of infiltration, one-way 
ANOVA). Dots correspond to individual T cell tracks.
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infiltrating CTLs were CD25+ GranzymeB+ and 56% produced 
IFNγ after in vitro restimulation, the percentage of bona fide 
effectors was reduced to <23% in anti-MHC class II-treated 
mice (Figure  4D; Figure S5A in Supplementary Material). 
Furthermore, the remaining CD8+ CD25+ GranzymeB+ 
T  cells expressed those markers at lower levels than controls 
(Figure  4E). Notably, HNT-CFP CD4+ T  cells also displayed 
reduced effector potential in the absence of antigenic stimula-
tion, as evidenced by a decrease in their ability to produce IL-2 
and IFNγ (Figure S5B in Supplementary Material). Thus, this 
indicates that help mediated by beta cell antigen-specific CD4+ 
T cells is required to maintain the functionality of diabetogenic 
CTL in the pancreas.
Finally, we evaluated whether this decline in CTL effector 
potential could impact disease progression by treating trans-
ferred InsHA-mCherry mice with anti-MHC class II from day 
8 post-T  cell transfer, every 3  days, for a 30-day period. All 
control mice became rapidly diabetic and had to be sacrificed 
(Figure  4F). Conversely, anti-MHC class II treatment delayed 
onset of hyperglycemia (Figure 4F). Strikingly, anti-MHC class 
II-treated mice, even with elevated blood glucose levels, remained 
healthy for longer periods and 44% survived until the end of the 
experiment (Figure 4G). Although the initial delay in the onset of 
hyperglycemia may result from the fact that fewer T cells infiltrate 
the pancreas, ulterior stabilization of blood glucose levels likely 
reflects the loss of effector function by diabetogenic CTL.
FigUre 4 | Major histocompatibility complex (MHC) class II-dependent CD4+ T cell help supports CD8+ T cell effector function in the pancreas. Irradiated 
InsHA-mCherry mice transferred with clone 4-GFP CD8+ and HNT-CFP CD4+ T cells were treated on days 8 and 9 with either anti-MHCII- or isotype-matched 
control mAb and sacrificed on day 10. (a) Detection of Thy1.1+ donor clone 4-GFP CD8+ and HNT-CFP CD4+ T cells in LN and pLN. Values represent mean ± SEM 
of the percentages of donor T cells in singlets living lymphocytes (n = 5 mice/group, Mann–Whitney U-test). (B) Phenotype of CD8+ Thy1.1+ donor lymphocytes in 
the LN and pLN of representative individual mice. Graphs depict percentages of different subpopulations of donor CD8+ T cells. Values correspond to mean ± SEM 
(n = 4 mice/group, Mann–Whitney U-test). (c) Detection of Thy1.1+ donor clone 4-GFP CD8+ and HNT-CFP CD4+ T cells in the pancreas. Values represent 
mean ± SEM of total detected events from individual pancreas (n = 5 mice/group, Mann–Whitney U-test). (D) Phenotype of clone 4-GFP CD8+ Thy1.1+ donor 
lymphocytes in the pancreas of representative individual mice. Graphs depict percentages of different subpopulations of donor clone 4-GFP CD8+ T cells in the 
pancreas. Values correspond to mean ± SEM (n = 3–5 mice/group, Mann–Whitney U-test). (e) Graphs depict the mean fluorescence intensity (MFI) of CD25 and 
granzyme B (GrazB) minus that of matched isotype control staining in the CD8+ Thy1.1+ CD25+ GrazB+ T cell subpopulations described in (D). Values represent 
mean ± SEM (n = 3–5 mice per group, Mann–Whitney U-test). Data from one representative experiment of two, Mann–Whitney U-test. (F) Irradiated InsHA-mCherry 
mice transferred with clone 4-GFP CD8+ and HNT-CFP CD4+ T cells were treated from day 8 posttransfer every 3 days with either anti-MH II- or isotype-matched 
control antibody. Blood glucose levels over time post-T cell transfer, mean ± SEM (n = 9 mice/group, two independent experiments). (g) Survival curve of mice 
described in (F).
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DiscUssiOn
Dynamic influxes of different immune cell types in pancreatic 
islets lead to beta cell destruction (2, 29). While CD8+ and CD4+ 
T  lymphocytes usually represent the dominant immune cell 
populations and independently play a key role in beta cell killing 
(9, 33), whether they are able to collaborate in islet destruction 
remained unknown. By using two-photon microscopy in  vivo 
to visualize HA-specific CD8+ and CD4+ T cells in the pancreas 
of mice expressing HA in beta cells, we found that CD4+ T cells 
displayed MHC class II-dependent increased arrest in the 
exocrine tissue. CD4+ T cell arrest locally correlated with APC 
recruitment, which infiltrating CD4+ T  cells were sufficient 
to trigger. Finally, infiltrated effector CD8+ T  cells deprived of 
continued help through anti-MHC class II antibody treatment 
failed to maintain optimal effector functions specifically in the 
pancreas, which, together with reduced effector T cell infiltration, 
hampered diabetes progression. These results support a crucial 
role for effector CD4+ T helper cells in sustaining effector func-
tions of CTLs at target sites.
In accordance with previous studies (14, 29), insulitis was het-
erogeneous. Notably, islets infiltrated by a few T cells contained 
both CD8+ and CD4+ T cells, suggesting that timing of infiltration 
is similar for both T cell types, albeit in different ratio. Both T cell 
populations migrated outside islets at average velocities similar 
to those described for T cells in peripheral tissues (26, 34). Their 
motility increased with infiltration levels (14), and arrest in islets 
was high, consistent with antigen recognition (9). By contrast 
with CD8+ T  cells, CD4+ T  cells presented a marked arrest in 
the exocrine tissue, correlating with recruitment of both DCs 
and macrophages. Local recruitment of APCs may serve different 
purposes. First, recruited macrophages may directly participate 
in beta cell killing (35). Second, recruited APCs may phagocy-
tose killed cells, promoting beta cell antigen presentation and 
amplifying T cell activation. Finally, local aggregation of APCs 
may restrict T cell migration to favor induction or maintenance 
of effector functions and CTL proliferation (15, 36, 37).
Long-lasting CD8+ T  cell responses are dependent on CD4 
help in non-lymphoid tissues (16, 38). Evidence points to DCs as 
key mediators in this process. First, most MHC class II-expressing 
cells in the exocrine tissue here correspond to CD103+ DCs. 
Second, both beta cell antigen-specific CD8+ and CD4+ T cells 
have been independently shown to engage in antigen-mediated 
interactions with DCs (13, 14). Finally, anti-MHCII treatment 
decreased T  cell arrest. While blockade of antigen recognition 
directly impairs CD4+ T cell/APC interactions, decreased CD8+ 
T cell arrest suggests an indirect effect. Since CD4+/APCs clusters 
may attract CD8+ T cells (39), CD8+ T cells might be more likely 
to contact APCs once they are or have already been in contact 
with CD4+ T cells, as described in LN (19, 20). This may explain 
why CD4+/DC/CD8+ clusters could be frequently detected by 
confocal experiments. However, further experiments would be 
required to evaluate the importance of three-cell type interactions 
in help delivery.
Finally, anti-MHCII antibody treatment at a time when 
antigen-driven activation of HA-specific T cells in the pLN has 
already occurred and effector T cells have already infiltrated the 
pancreas affected the expression of markers linked to effector 
functions in HA-specific CD8+ T  cells. This supports a pivotal 
role for continued CD4+ T  cell help, mediated by APCs, in 
maintaining CD8+ T cell killer efficiency in the pancreas. CTLs 
generated with CD4 help in pLN may thus not be programmed to 
retain effector functions in the pancreas and need continued help 
for optimal functionality. Consistent with antigen-dependent 
CD4+ T  cell extravasation in the pancreas facilitated by DCs 
(32), anti-MHCII treatment impaired CD4+ T cell recruitment. 
Interestingly, CD8+ T  cell numbers were also affected, reflect-
ing the role of CD4+ T cells in CD8+ T cell recruitment and/or 
proliferation in the pancreas (16). The delay in blood glucose rise 
and later stabilization of both blood glucose levels and general 
health thus likely reflect a combined effect of the reduced effector 
cell infiltration and the reduced ability of helpless effector CD8+ 
T cells to sustain beta cell destruction.
Precise mechanisms underlying help delivery upon antigen 
recognition in the pancreas still need further investigation. In 
LNs, CD40-mediated licensing of DCs by CD4+ T cells induces 
the expression of co-stimulatory molecules and constitutes the 
main pathway of CD4 help for naive CD8+ T cell priming (40). 
However, requirements for effector CD8+ T cell restimulation are 
likely to be less stringent. Supporting this, pancreatic DCs from 
anti-MHCII-treated mice displayed similar levels of co-stim-
ulatory molecules as controls (our unpublished observations). 
Alternatively, the facts that antitumor CTL rely on IL-2 and IFNγ 
for tumor rejection (16) and that pancreatic HNT CD4+ T cells 
were able here to secrete IFNγ and IL-2 in response to antigen 
suggest that these cytokines may be involved in providing help to 
clone 4 CD8+ T cells. A tantalizing prospect is that DCs may serve 
as a platform for delivering these cytokines.
In summary, we reveal a pivotal role for continued CD4 help 
in maintaining CD8+ T cell effector function in the pancreas and 
in autoimmune diabetes progression and thus unveil an unprec-
edented role for cooperation between effector CD4+ and CD8+ 
T cells that may have important implications for the design of new 
therapeutic strategies against T1D.
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